Cardiol Therapeutics Inc.
CRDL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001702123
No open-market purchases or sales by Cardiol Therapeutics Inc. insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $31.3M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Cardiol Therapeutics Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 47 | 52 | +5 |
| Shares | 27.9M | 29.5M | +1.64M (+5.9%) |
| Value | $37.6M | $31.3M | −$6.30M (−16.8%) |
New holders (11)
Institutions that held Cardiol Therapeutics Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 47,179 | $50.0K | 0.00% |
| Acadian Asset Management LLC | 44,255 | $45.0K | 0.00% |
| Concurrent Investment Advisors, LLC | 25,387 | $26.9K | 0.00% |
| Wealth Enhancement Advisory Services, LLC | 22,340 | $22.6K | 0.00% |
| Aurora Private Wealth, Inc. | 21,000 | $22.0K | 0.01% |
| Point72 Asset Management, L.P. | 18,354 | $19.5K | 0.00% |
| Creative Planning | 17,609 | $18.7K | 0.00% |
| LPL Financial LLC | 12,610 | $13.4K | 0.00% |
| SRS Capital Advisors, Inc. | 1,724 | $1.83K | 0.00% |
| Group One Trading, L.P. | 366 | $388 | 0.00% |
| Caitong International Asset Management Co., Ltd | 11 | $12 | 0.00% |
Sold out (6)
Institutions that held Cardiol Therapeutics Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Knoll Capital Management, LLC | 100,000 | $135.0K |
| Susquehanna International Group, LLP | 70,396 | $95.0K |
| Virtu Financial LLC | 23,917 | $32.0K |
| Scientech Research LLC | 15,178 | $20.5K |
| BNP Paribas Arbitrage, SA | 10,000 | $13.5K |
| Baader Bank INC | 15,932 | $10.2K |